The impact of ticagrelor therapy on CABG-related bleeding in patients with STEMI managed with pPCI and following on-pump CABG-Reference-Cited by-同舟云学术

The impact of ticagrelor therapy on CABG-related bleeding in patients with STEMI managed with pPCI and following on-pump CABG

Published:2024-07-20 Issue: Volume: Page:
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Durmaz Eser^ORCID,Ikitimur Baris,Arapi Berk,Tel Ustunisik Cigdem,Soysal Ali Ugur,İncesu Gunduz,Gulfidan Aslı,Yalman Hakan,Cidem Savas,Tokdil Hasan,Raimoglu Utku,Raimoglou Damla,Akman Zafer,Atici Adem,Karadag Bilgehan

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00380-024-02434-1.pdf

Reference14 articles.

1. Arslan F, Bongartz L, ten Berg JM, Jukema JW, Appelman Y, Liem AH, de Winter RJ, van ’t Hof AWJ, Damman P (2018) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group. Netherlands Heart J 26:417–421

2. Engstrøm T, Kelbæk H, Helqvist S et al (2015) Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. The Lancet 386:665–671

3. Cui K, Zhang D, Lyu S, Song X, Yuan F, Xu F, Zhang M (2018) Meta-analysis comparing percutaneous coronary revascularization using drug-eluting stent versus coronary artery bypass grafting in patients with left ventricular systolic dysfunction. Am J Cardiol 122:1670–1676

4. Goel SS, Shishehbor MH (2013) Strategies for multivessel revascularization in patients with diabetes. Cardiol Rev 29:2375–2384

5. Serruys PW, Morice M-C, Kappetein AP et al (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360:961–972